Palbociclib price in Singapore (2026)

There is no fixed public retail price for palbociclib in Singapore in the sources we track (most supply is hospital- or named-patient based). Use the Bangladesh list price as the benchmark: BDT 400–BDT 400 (US$3.26–US$3.26) per unit, about SGD 4.167–SGD 4.167 in SGD per unit and SGD 125.01–SGD 125.01 per 30-unit month, before freight, customs duty and distributor margin.

Yes, but only through the rules of the Health Sciences Authority (HSA): Singapore is a high-income market with strict HSA registration and no national price control, so prices stay close to originator levels even for registered generics. Unregistered medicines may only be imported under HSA authorisation for a named patient. Prescription medicines must move on a valid prescription through a licensed importer, pharmacy or hospital; personal-use imports need a named-patient / compassionate-use authorisation.

We cannot confirm the registration status of every individual generic brand in Singapore. Health Sciences Authority (HSA) is the approving authority, and only products with a local product registration (or a special import authorisation) may be sold routinely. Ask your supplier for the local registration or import permit for the specific brand before you buy.

Bangladesh is a least-developed-country WTO member with a pharmaceutical patent exemption running to 2033, so local manufacturers can legally produce molecules that are still on patent elsewhere — and DGDA-registered list prices are public. That makes it the practical global floor price for on-patent targeted therapy and the benchmark used in import negotiations.

Singapore: registered. Palbociclib products registered with HSA and listed in the Singapore National Drug Formulary (e.g. PALBONAT CAPSULES 75MG [SIN17422P]; palbociclib tablets 75/100/125 mg)